Cargando…
A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19)
Autores principales: | Keshtkar-Jahromi, Maryam, Bavari, Sina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204586/ https://www.ncbi.nlm.nih.gov/pubmed/32247318 http://dx.doi.org/10.4269/ajtmh.20-0230 |
Ejemplares similares
-
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings
por: Abena, Pascale M., et al.
Publicado: (2020) -
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19
por: Lee, Zelyn, et al.
Publicado: (2021) -
Storytelling and poetry in the time of coronavirus
por: Barrett, Elizabeth, et al.
Publicado: (2020) -
Effect of SARS-CoV-2 Infection in Pregnancy on Maternal and Neonatal Outcomes in Africa: An AFREhealth Call for Evidence through Multicountry Research Collaboration
por: Nachega, Jean B., et al.
Publicado: (2021) -
Advanced Preparation Makes Research in Emergencies and Isolation Care
Possible: The Case of Novel Coronavirus Disease (COVID-19)
por: Brett-Major, David M., et al.
Publicado: (2020)